MurugesanManoharanMDFRACS(Urol), FRCS(Eng)

Minimally Invasive Surgery, Surgical Oncology, Trauma & Reconstructive Surgery

Chief / Urologic Oncology, Director / Robotic Urologic Surgery, Miami Cancer Institute, Baptist Health

Overview of Dr. Manoharan

Dr. M. Manoharan MD, FRCS(Eng), FRACS(Urol) is the "Chief of Urologic Oncology and the Director of Robotic Urologic Surgery" at the "Miami Cancer Institute, Baptist Health South Florida, Miami, USA ". He is internationally known for his expertise in Urologic Oncology, Robotic surgery, Neobladder reconstruction and other urinary reconstruction . He has served a member in the International bladder cancer guidelines committee. He has delivered several lectures in both national and international scientific meetings and conducted urological workshops. He has published more than 140 articles in peer reviewed journals and authored 15 text book chapters. He is an active investigator in several Urologic Oncology research studies. He completed his urology training in New Zealand and Urologic Oncology training at University of Miami.

Office
8900 N Kendall Dr
# Miami
Miami, FL 33176
Book by Phone+1(786) 396-6530

Fax+1 305-279-7778

Clinical Expertise

Minimally invasive urologic surgery, Urologic oncology, Robotic surgery, laparoscopic surgery, urologic oncology, reconstruction, Robotic prostatectomy, Orthotopic bladder substitution, Robotic partial nephrectomy, Robotic nephrectomy, Radical cystectomy, Lymphadenectomy, Ureteral reconstruction, Ileal conduit, Ben ign prostatic hyperplasia, Greenlight laser therapy for benign prostatic hyperplasia, Urethral cancer, Micropapillary carcinoma

Education & Training

University of Miami Hospital and ClinicsFellowship, Urologic Surgical Oncology, 2002 - 2003
Madras Medical CollegeClass of 1988

Certifications & Licensure

FL State Medical License 2003 - 2025
IN State Medical License 2005 - 2017
IA State Medical License 2005 - 2015
American Board of Urology Urology

Awards, Honors, & Recognition

Best Urology Teacher of the Year Department of Urology, University of Miami, 2004, 2007, 2009, 2013, 2015
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
Withdrawn
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Start of enrollment: 2016 Jan 05
Terminated
Not Applicable
MRI Based Active Selection for Treatment Trial Start of enrollment: 2014 Nov 12
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement.
Nathan VanderVeer-Harris, Zachary D Zippi, Dev P Patel, Murugesan Manoharan, Jorge R Caso
Journal of Medical Screening. 2024-12-01
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer.
Arjun Pon Avudaiappan, Pushan Prabhakar, Rachel Siretskiy, Andrew Renshaw, Ahmed Eldefrawy
BJUI Compass. 2024-11-01
Cytologic diagnosis of papillary renal neoplasm with reverse polarity.
Sarah J Wu, Andrew A Renshaw, Peter M Sadow, Navin R Mahadevan, Michelle S Hirsch
Cancer Cytopathology. 2024-09-11

Press Mentions

The Challenges with Using Targeted Therapies in Ovarian Cancer SpaceMarch 25th, 2023
New Technology Leads to More Accurate Prostate Cancer Diagnosis and TreatmentsMay 24th, 2021
Miami Cancer Institute Names Murugesan Manoharan, as Chief of Urologic Oncology SurgeryFebruary 19th, 2017
Join now to see all